Accessibility Menu
Arrow-Thin-Down
S&P 500
6,791.69
+0.8%
+53.25
Arrow-Thin-Down
DJI
47,207.12
+1.0%
+472.51
Arrow-Thin-Down
NASDAQ
23,204.87
+1.1%
+263.07
Arrow-Thin-Down
Bitcoin
$111,672.00
+0.6%
+$685.76
Arrow-Thin-Down
AAPL
$262.83
+1.3%
+$3.25
Arrow-Thin-Down
AMZN
$224.25
+1.4%
+$3.16
Arrow-Thin-Down
GOOG
$260.59
+2.7%
+$6.86
Arrow-Thin-Down
META
$738.67
+0.6%
+$4.67
Arrow-Thin-Down
MSFT
$523.61
+0.6%
+$3.05
Arrow-Thin-Down
NVDA
$186.29
+2.3%
+$4.13
Arrow-Thin-Down
TSLA
$433.88
-3.4%
-$15.10
Daily Stock GainersDaily Stock LosersMost Active Stocks
Global Medical REIT Stock Quote

Global Medical REIT (NYSE: GMRE)

$32.29
(0.9%)
+0.30
Price as of October 24, 2025, 3:52 p.m. ET

KEY DATA POINTS

Current Price
$32.29
Daily Change
(0.9%) +$0.30
Day's Range
$31.95 - $32.36
Previous Close
$32.29
Open
$31.95
Beta
0.84
Volume
2,964
Average Volume
189,290
Sector
Real Estate
Market Cap
431M
Market Cap / Employee
$32.15M
52wk Range
$30.09 - $47.05
Revenue
-
Gross Margin
0.45%
Dividend Yield
11.20%
EPS
$0.34
CAPs Rating
-
Industry
Health Care REITs

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Global Medical REIT Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
GMRE-24.49%-26.56%-5.98%-62%
S&P+16.9%+95.99%+14.39%+326%

Global Medical REIT Company Info

Global Medical REIT, Inc. engages in the acquisition of purpose-built healthcare facilities and the leasing of those properties to healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

News & Analysis

Featured Article

2 High-Yielding Dividend Stocks Worth the Risk and 1 That Isn't

Not all medical REITs are created equal.

James Halley  |  Oct 26, 2022
Featured Article

3 Unknown but Amazing Dividend Stocks

Profit by seeking cash flow where few others look.

Will Healy  |  Nov 22, 2020

Financial Health

General

Q2 2025YOY Change
Revenue$41.27M6.7%
Gross Profit$17.76M1.8%
Gross Margin43.04%-2.1%
Market Cap$463.47M-22.2%
Market Cap / Employee$17.83M0.0%
Employees260.0%
Net Income$0.59M130.0%
EBITDA$27.03M0.7%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$9.78M11.9%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$719.14M15.0%
Short Term Debt$13.56M5177.4%

Ratios

Q2 2025YOY Change
Return On Assets0.81%0.4%
Return On Invested Capital1.00%-0.1%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$18.32M-216.5%
Operating Free Cash Flow$22.14M17.0%

Valuation

MetricQ1 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings38.46647.65279.73102.97109.34%
Price to Book1.421.121.321.08-9.13%
Price to Sales4.223.313.792.95-22.87%
Price to Tangible Book Value6.835.596.455.31-11.83%
Enterprise Value to EBITDA51.1652.7451.1547.48-2.63%
Return on Equity0.8%1.2%1.5%1.9%98.07%
Total Debt$640.06M$657.53M$692.17M$732.70M17.13%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services